Tags

Type your tag names separated by a space and hit enter

[Medical indications and effectiveness of the pneumococcal conjugate vaccine].
Laryngorhinootologie. 2006 Apr; 85(4):291-8; quiz 299-300.L

Abstract

Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, sinusitis, and acute otitis media in children and adults worldwide. Especially in the age group of < 2 years the incidence of invasive pneumococcal is high. The vulnerability of children to S. pneumoniae can also be demonstrated by the high rate of sequelae (> 20 % in Germany) and the high mortality (7.5 %) in pneumococcal meningitis. A 7-valent pneumococcal conjugate vaccine that was shown to be highly efficacious in preventing invasive pneumococcal disease in infants in the USA was licensed in Europe in 2001. It is expected that broad usage of the vaccine would reduce the incidence of invasive pneumococcal disease and the levels of pneumococcal resistance significantly.

Links

Publisher Full Text

Authors+Show Affiliations

Reinert RR
Nationales Referenzzentrum für Streptokokken, Aachen. Reinert@rwth-aachen.de

MeSH

AdolescentAdultChildChild, PreschoolDrug ApprovalGermanyHumansInfantMeningitis, PneumococcalOtitis MediaPneumococcal InfectionsPneumococcal VaccinesPneumonia, PneumococcalSinusitisTreatment OutcomeVaccines, Conjugate

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

16615030

Citation

Reinert, R R.. "[Medical Indications and Effectiveness of the Pneumococcal Conjugate Vaccine]." Laryngo- Rhino- Otologie, vol. 85, no. 4, 2006, pp. 291-8; quiz 299-300.
Reinert RR. [Medical indications and effectiveness of the pneumococcal conjugate vaccine]. Laryngorhinootologie. 2006;85(4):291-8; quiz 299-300.
Reinert, R. R. (2006). [Medical indications and effectiveness of the pneumococcal conjugate vaccine]. Laryngo- Rhino- Otologie, 85(4), 291-8; quiz 299-300.
Reinert RR. [Medical Indications and Effectiveness of the Pneumococcal Conjugate Vaccine]. Laryngorhinootologie. 2006;85(4):291-8; quiz 299-300. PubMed PMID: 16615030.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Medical indications and effectiveness of the pneumococcal conjugate vaccine]. A1 - Reinert,R R, PY - 2006/4/15/pubmed PY - 2006/7/11/medline PY - 2006/4/15/entrez SP - 291-8; quiz 299-300 JF - Laryngo- rhino- otologie JO - Laryngorhinootologie VL - 85 IS - 4 N2 - Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, sinusitis, and acute otitis media in children and adults worldwide. Especially in the age group of < 2 years the incidence of invasive pneumococcal is high. The vulnerability of children to S. pneumoniae can also be demonstrated by the high rate of sequelae (> 20 % in Germany) and the high mortality (7.5 %) in pneumococcal meningitis. A 7-valent pneumococcal conjugate vaccine that was shown to be highly efficacious in preventing invasive pneumococcal disease in infants in the USA was licensed in Europe in 2001. It is expected that broad usage of the vaccine would reduce the incidence of invasive pneumococcal disease and the levels of pneumococcal resistance significantly. SN - 0935-8943 UR - https://www.unboundmedicine.com/medline/citation/16615030/[Medical_indications_and_effectiveness_of_the_pneumococcal_conjugate_vaccine]_ L2 - https://www.thieme-connect.com/DOI/DOI?10.1055/s-2005-870569 DB - PRIME DP - Unbound Medicine ER -